Last reviewed · How we verify
NCT03268408: BabyNewsletter
Impact Evaluation of the "Baby Newsletter"
trial testing Baby Newsletter in Parenting in 136 participants. Completed in 31 December 2018.
31 December 2015
Quick facts
| Lead sponsor | Azienda USL Reggio Emilia - IRCCS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 136 |
| Start date | 1 September 2014 |
| Primary completion | 31 December 2015 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Baby Newsletter
Conditions studied
- Parenting — all drugs for Parenting →
Sponsor
Azienda USL Reggio Emilia - IRCCS — full company profile →
Who can join
Eligibility, any sex, with Parenting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Not-randomized controlled study to evaluate a community intervention to promote self-efficacy parenting. The treated group will be composed by all newborns resident in S.Ilario d'Enza (105 in 2013) where the Baby Newsletter is implemented. Newborns resident in the Health District of Montecchio and born in Montecchio Hospital in the same period are the control group (278 in 2013). Preterm or hospitalized children are excluded. Self-efficacy parenting is evaluated through a questionnaire administered at baseline, after 5 and 12 months.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of an intervention aimed at supporting new parents: the Baby Newsletter project.
Panza C, Volta A, Broccoli S, Bonvicini L, et al · · 2020 · cited 3× · PMID 32887637 · DOI 10.1186/s13052-020-00886-5
Verify or expand the search:
- PubMed search for NCT03268408
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parenting
Currently open trials in the same condition.
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT06823518 — Thrive Initiative Parent-Education Programming Study · NA · recruiting
- NCT07494786 — Palestinian ParentText for Crisis · NA · recruiting
- NCT06569303 — Filipino Family Health Initiative 1.0 · NA · recruiting
- NCT07008651 — Digital Parenting Education: Impact on Mothers' Social Media Use and Children's Tech Attitudes · NA · recruiting
Other Azienda USL Reggio Emilia - IRCCS trials
Trials by the same sponsor.
- NCT07373626 — Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic · recruiting
- NCT07000162 — LAttice Radiation Therapy for Large Lesions: Reggio Emilia Single-arm Phase II Trial · Phase 2 · recruiting
- NCT06629896 — Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomize · NA · recruiting
- NCT06749600 — Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma · recruiting
- NCT06624280 — Does Orthopedic Surgery Improve Gait Efficiency in Children With Cerebral Palsy? A Retrospective Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03268408 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda USL Reggio Emilia - IRCCS
- Last refreshed: 25 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03268408.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing